Integrated System for Prevention, Diagnosis, and Treatment of Drug-Induced Oral Lesions in Patients with Comorbid Pathology

Ravshanova Odinabonu Temurzjon kizi

Authors

Ravshanova Odinabonu Temurzjon kizi Tashkent State Dental University

Vol. 3 No. 9 (2025): International Journal of Integrative and Modern Medicine

Articles

September 15, 2025

Downloads

View Article

Abstract
How to Cite
Metrics
References

Drug-induced oral lesions represent a serious medical problem in modern clinical practice, which becomes particularly relevant in the context of constant expansion of pharmacological arsenal and increasing life expectancy of the population. According to the World Health Organization (WHO), the incidence of adverse drug reactions in the oral cavity ranges from 3.2% to 12.8% among all hospitalized patients, while in patients with comorbid pathology this indicator increases to 18-25%.

kizi, R. O. T. (2025). Integrated System for Prevention, Diagnosis, and Treatment of Drug-Induced Oral Lesions in Patients with Comorbid Pathology. International Journal of Integrative and Modern Medicine, 3(9), 85–88. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/2092

Download Citation

1. Abdullaev A.M. Clinical and morphological features of drug-induced lesions of the oral mucosa / A.M. Abdullaev, S.R. Karimova // Stomatology of Uzbekistan. – 2021. – № 3. – P. 15-22.

2. Akhmedov R.Kh. Pharmacological aspects of xerostomia development in patients with arterial hypertension / R.Kh. Akhmedov, N.U. Tursunova // Medical Journal of Uzbekistan. – 2020. – № 4. – P. 78-84.

3. Ismailov B.S. Comorbid pathology and risk of developing dental complications of pharmacotherapy / B.S. Ismailov // Clinical Pharmacology and Therapy. – 2019. – Vol. 28, № 2. – P. 45-51.

4. Karimova L.A. Diagnosis and treatment of drug-induced gingival hyperplasia / L.A. Karimova, M.R. Rakhimov // Periodontology. – 2021. – № 1. – P. 32-38.

5. Mamatkulov O.R. Prevention of drug-induced oral lesions in oncological patients / O.R. Mamatkulov, Z.I. Usmanova // Oncology and Radiology of Kazakhstan. – 2020. – № 3. – P. 67-73.

6. Norbekov Zh.M. Personalized approach to managing patients with polypharmacy in dental practice / Zh.M. Norbekov // New Day in Medicine. – 2021. – № 4. – P. 125-132.

7. Rakhimova D.N. Drug interactions and development of orofacial complications / D.N. Rakhimova, A.K. Yuldashev // Postgraduate Doctor. – 2019. – Vol. 97, № 6. – P. 28-35.

8. Salimov O.A. Integrated approach to prevention of dental complications in patients with diabetes mellitus / O.A. Salimov, Sh.B. Kadyrova // Endocrinology of Uzbekistan. – 2020. – № 2. – P. 89-96.

9. Al-Dwairi Z.N. Drug-induced oral reactions in patients with chronic diseases / Z.N. Al-Dwairi, M.A. Alsmadi // Int J Dent Hyg. – 2020. – Vol. 18, № 2. – P. 203-210.

10. Baek S.K. Drug-induced oral and dental adverse effects / S.K. Baek, H.J. Kim, Y.J. Lee // Hanyang Med Rev. – 2019. – Vol. 39, № 4. – P. 215-222.

11. Bascones-Martinez A. Oral manifestations of drug reactions / A. Bascones-Martinez, M. Figuero-Ruiz // Med Oral Patol Oral Cir Bucal. – 2019. – Vol. 24, № 3. – P. e321-e330.

12. Chen Y.W. Drug-induced oral lichenoid reactions: A systematic review / Y.W. Chen, M.Y. Lin, P.C. Yang // Oral Dis. – 2021. – Vol. 27, № 5. – P. 1099-1110.

13. De Rossi S.S. Drug-induced gingival enlargement / S.S. De Rossi, P.B. Ferreira // Periodontol 2000. – 2020. – Vol. 83, № 1. – P. 92-106.

14. Femiano F. Drug-induced oral ulcerations / F. Femiano, N. Scully // Oral Dis. – 2019. – Vol. 25, № 6. – P. 1423-1436.

15. Garcia-Pola M. Risk factors for drug-induced oral manifestations / M. Garcia-Pola, J. Bagán, L. Cerero // J Eur Acad Dermatol Venereol. – 2021. – Vol. 35, № 4. – P. 891-899.

International Journal of Integrative and Modern Medicine

Integrated System for Prevention, Diagnosis, and Treatment of Drug-Induced Oral Lesions in Patients with Comorbid Pathology

Authors

Downloads

Similar Articles

menu

Our Journal

SocialShare

counter

Information